These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27051408)

  • 21. How well do standard stroke outcome measures reflect quality of life? A retrospective analysis of clinical trial data.
    Ali M; Fulton R; Quinn T; Brady M;
    Stroke; 2013 Nov; 44(11):3161-5. PubMed ID: 24052510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biochemical predictors of late-outcome in patients after ischemic stroke.
    Bielewicz JE; Kurzepa J; Kamieniak P; Daniluk B; Szczepańska-Szerej A; Rejdak K
    Ann Agric Environ Med; 2020 Jun; 27(2):290-294. PubMed ID: 32588608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
    Pektezel MY; Yilmaz E; Arsava EM; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1853-1859. PubMed ID: 31072698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
.
    Maruyama K; Uchiyama S; Shiga T; Iijima M; Ishizuka K; Hoshino T; Kitagawa K
    Cerebrovasc Dis Extra; 2017; 7(1):35-43. PubMed ID: 28253498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis.
    Balucani C; Levine SR; Khoury JC; Khatri P; Saver JL; Broderick JP
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):894-901. PubMed ID: 26825352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
    Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
    Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effectiveness of Qilong capsule in patients with ischemic stroke: A prospective, multicenter, non-randomized controlled trial.
    Lyu J; Gao Y; Wei R; Cai Y; Shen X; Zhao D; Zhao X; Xie Y; Yu H; Chai Y; Xie Y
    Phytomedicine; 2022 Sep; 104():154278. PubMed ID: 35780589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation of a Prediction Rule for Unfavorable Outcome after Ischemic Stroke in the Chinese Population.
    Mao H; Wu Q; Lin P; Mo J; Jiang H; Lin S; Rainer TH; Chen X
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):133-141. PubMed ID: 30337207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Trajectory of Stroke Severity Predicts Long-Term Functional Outcomes in Ischemic Stroke Subjects: Results From the ESCAPE Trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times).
    Sajobi TT; Menon BK; Wang M; Lawal O; Shuaib A; Williams D; Poppe AY; Jovin TG; Casaubon LK; Devlin T; Dowlatshahi D; Fanale C; Lowerison MW; Demchuk AM; Goyal M; Hill MD;
    Stroke; 2017 Jan; 48(1):105-110. PubMed ID: 27924049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators.
    Lyden P; Lu M; Jackson C; Marler J; Kothari R; Brott T; Zivin J
    Stroke; 1999 Nov; 30(11):2347-54. PubMed ID: 10548669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
    Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
    Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.
    Hallevi H; Albright KC; Martin-Schild SB; Barreto AD; Morales MM; Bornstein N; Ifejika NL; Shuaib A; Grotta JC; Savitz SI;
    Cerebrovasc Dis; 2009; 28(4):341-8. PubMed ID: 19628935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of the NIHSS for ADL outcome after ischemic hemispheric stroke: does timing of early assessment matter?
    Kwakkel G; Veerbeek JM; van Wegen EE; Nijland R; Harmeling-van der Wel BC; Dippel DW;
    J Neurol Sci; 2010 Jul; 294(1-2):57-61. PubMed ID: 20439108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Twenty-four-hour National Institute of Health Stroke Scale predicts short- and long-term outcomes of basilar artery occlusion after endovascular treatment.
    Chen J; Liu S; Wu M; Dai L; Wang J; Xie W; Peng Y; Mu J; Yang S; Ran J; Zhang J; Niu W; Zheng J; Wu J; Yuan G
    Front Aging Neurosci; 2022; 14():941034. PubMed ID: 36337700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of hyperdense middle cerebral artery sign on follow-up CT scan after intravenous thrombolysis is associated with poor outcome.
    Paliwal PR; Ahmad A; Shen L; Yeo LL; Loh PK; Ng KW; Chong VF; Ong BK; Venketasubramanian N; Sinha AK; Teoh HL; Bathla G; Chan BP; Sharma VK
    Cerebrovasc Dis; 2012; 33(5):446-52. PubMed ID: 22456065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA; Al-Senani F; Wojner AW; Grotta JC; Malkoff M; Alexandrov AV
    Stroke; 2003 Mar; 34(3):695-8. PubMed ID: 12624293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke recovery profile and the Modified Rankin assessment.
    Lai SM; Duncan PW
    Neuroepidemiology; 2001 Feb; 20(1):26-30. PubMed ID: 11174042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.